These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15320753)

  • 1. Cardiac sarcolemmal ion channels and transporters as possible targets for antiarrhythmic and positive inotropic drugs: strategies of the past--perspectives of the future.
    Varro A; Nanasi PP; Acsai K; Virag L; Papp JG
    Curr Pharm Des; 2004; 10(20):2411-27. PubMed ID: 15320753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological modulation of ion channels and transporters.
    Ravens U; Wettwer E; Hála O
    Cell Calcium; 2004 Jun; 35(6):575-82. PubMed ID: 15110147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative inotropic effects of tetrodotoxin and seven class 1 antiarrhythmic drugs in relation to sodium channel blockade.
    Honerjäger P; Loibl E; Steidl I; Schönsteiner G; Ulm K
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):184-95. PubMed ID: 2422563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?
    Das B; Sarkar C
    Life Sci; 2005 Jul; 77(11):1226-48. PubMed ID: 15964023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels.
    Gögelein H; Brendel J; Steinmeyer K; Strübing C; Picard N; Rampe D; Kopp K; Busch AE; Bleich M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Sep; 370(3):183-92. PubMed ID: 15340774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic and Inotropic Effects of Selective Na
    Nagy N; Tóth N; Nánási PP
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KB130015, a new amiodarone derivative with multiple effects on cardiac ion channels.
    Mubagwa K; Macianskiene R; Viappiani S; Gendviliene V; Carlsson B; Brandts B
    Cardiovasc Drug Rev; 2003; 21(3):216-35. PubMed ID: 12931255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties.
    Antzelevitch C; Belardinelli L; Zygmunt AC; Burashnikov A; Di Diego JM; Fish JM; Cordeiro JM; Thomas G
    Circulation; 2004 Aug; 110(8):904-10. PubMed ID: 15302796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of taurine-magnesium coordination compound on ionic channels in rat ventricular myocytes of arrhythmia induced by ouabain.
    Zhao L; Lou J; Wu H; Yin Y; Kang Y
    Biol Trace Elem Res; 2012 Jun; 147(1-3):275-84. PubMed ID: 22311082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficiency of Na+/Ca2+ exchanger or Na+/H+ exchanger inhibition and their combination in reducing coronary reperfusion-induced arrhythmias.
    Szepesi J; Acsai K; Sebok Z; Prorok J; Pollesello P; Levijoki J; Papp JG; Varro A; Toth A
    J Physiol Pharmacol; 2015 Apr; 66(2):215-26. PubMed ID: 25903952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of a Novel Highly Selective Inhibitor of the Sodium/Calcium Exchanger (NCX) on Cardiac Arrhythmias in In Vitro and In Vivo Experiments.
    Kohajda Z; Farkas-Morvay N; Jost N; Nagy N; Geramipour A; Horváth A; Varga RS; Hornyik T; Corici C; Acsai K; Horváth B; Prorok J; Ördög B; Déri S; Tóth D; Levijoki J; Pollesello P; Koskelainen T; Otsomaa L; Tóth A; Baczkó I; Leprán I; Nánási PP; Papp JG; Varró A; Virág L
    PLoS One; 2016; 11(11):e0166041. PubMed ID: 27832106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 1st communication: phosphodiesterase III inhibitory effect and class III antiarrhythmic effect in guinea-pig heart.
    Hino M; Sugawara H; Yoshimura A; Ogura A; Yoshioka K; Sakato M; Endoh M
    Arzneimittelforschung; 1999 May; 49(5):398-406. PubMed ID: 10367101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atria-selective antiarrhythmic drugs in need of alliance partners.
    Peyronnet R; Ravens U
    Pharmacol Res; 2019 Jul; 145():104262. PubMed ID: 31059791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular electropharmacology of amiodarone.
    Kodama I; Kamiya K; Toyama J
    Cardiovasc Res; 1997 Jul; 35(1):13-29. PubMed ID: 9302343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ion channels and arrhythmias].
    Borchard U; Hafner D
    Z Kardiol; 2000; 89 Suppl 3():6-12. PubMed ID: 10810780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic therapy in atrial fibrillation.
    Ravens U
    Pharmacol Ther; 2010 Oct; 128(1):129-45. PubMed ID: 20624425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel pharmacological approaches for antiarrhythmic therapy.
    Ravens U
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Mar; 381(3):187-93. PubMed ID: 20082192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ionic mechanisms of action of class III antiarrhythmic drugs].
    Kuz'min VS; Rozenshtraukh LV
    Kardiologiia; 2010; 50(7):49-61. PubMed ID: 20659045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of action of antiarrhythmic drugs: from ion channel blockage to arrhythmia termination.
    Grant AO
    Pacing Clin Electrophysiol; 1997 Feb; 20(2 Pt 2):432-44. PubMed ID: 9058847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S; Duker G; Carlsson L
    Prog Biophys Mol Biol; 2008; 98(2-3):328-39. PubMed ID: 19038282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.